ALVOTECH revenue breakdown overview

ALVOTECH revenue for the last year amounted to 12.73 B ISK, the most of which — 12.46 B ISK — came from its highest performing source at the moment, Biosimilar Medicines, the year earlier bringing 11.80 B ISK. The greatest contribution to the revenue figure was made by Europe — last year it brought ALVOTECH 8.65 B ISK, and the year before that — 5.60 B ISK.